Vertex Pharmaceuticals
VRTX
VRTX
1,280 hedge funds and large institutions have $83.2B invested in Vertex Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 142 funds opening new positions, 484 increasing their positions, 485 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 1,201 → 1,280 (+79)
0% less repeat investments, than reductions
Existing positions increased: 484 | Existing positions reduced: 485
0.88% less ownership
Funds ownership: 93.15% → 92.27% (-0.88%)
Holders
1,280
Holding in Top 10
33
Calls
$474M
Puts
$397M
Top Buyers
| 1 | +$792M | |
| 2 | +$421M | |
| 3 | +$373M | |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$229M |
| 5 |
Morgan Stanley
New York
|
+$151M |
Top Sellers
| 1 | -$580M | |
| 2 | -$403M | |
| 3 | -$382M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$295M |
| 5 |
Jennison Associates
New York
|
-$272M |